Literature DB >> 8567993

Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases.

S Takiya1, T Tagaya, K Takahashi, H Kawashima, M Kamiya, Y Fukuzawa, S Kobayashi, A Fukatsu, K Katoh, S Kakumu.   

Abstract

AIMS: To investigate the effects of transforming growth factor beta 1 (TGF-beta 1) on regeneration and induction of apoptosis of liver cell and bile duct in various liver diseases.
METHODS: Formalin fixed paraffin wax sections of 18 liver tissue samples were obtained by needle biopsy, surgery, or necropsy; these included six liver cirrhosis, three obstructive jaundice; five fulminant hepatitis, one subacute hepatitis, and three normal liver. Expression of TGF-beta 1, apoptosis related Le(y) antigen, Fas antigen, a receptor for tumour necrosis factor, and biotin nick end labelling with terminal deoxynucleotidyl transferase mediated dUTP (TUNEL) for locating DNA fragmentation, was investigated histochemically.
RESULTS: TGF-beta 1 was expressed in areas of atypical bile duct proliferation, where bile duct continuously proliferated from liver cells. In occlusive jaundice and fulminant hepatitis, TUNEL was positive in nuclei and cytoplasm of metaplastic cells which formed incomplete bile ducts, and these cells appeared to extend from TGF-beta 1 expressing liver cells. Fas antigen was found only on the cell membrane of proliferated bile duct in fulminant hepatitis, which differed from TGF-beta 1 and TUNEL positive areas. Le(y) antigen was expressed in liver cell and bile duct at the areas with atypical bile duct proliferation, but its coexpression with TUNEL was rare.
CONCLUSIONS: TGF-beta 1 plays a role in the arrest of liver cell regeneration and atypical bile duct proliferation, and in areas of rapidly progressing atypical bile duct proliferation, such as in fulminant hepatitis or bile retention. Apoptosis appears to be induced by TGF-beta 1. This phenomenon may account for the inadequate hepatic regeneration that occurs with liver disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567993      PMCID: PMC503033          DOI: 10.1136/jcp.48.12.1093

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  33 in total

1.  Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

Authors:  L Braun; J E Mead; M Panzica; R Mikumo; G I Bell; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  A study of liver regeneration using fetal rat liver tissue transplanted into the spleen.

Authors:  H Ebata; K Onodera; M Sawa; M Mito
Journal:  Jpn J Surg       Date:  1988-09

3.  Interleukin-1 beta is a potent growth inhibitor of adult rat hepatocytes in primary culture.

Authors:  T Nakamura; R Arakaki; A Ichihara
Journal:  Exp Cell Res       Date:  1988-12       Impact factor: 3.905

4.  Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus.

Authors:  P S Bhathal; J A Gall
Journal:  Liver       Date:  1985-12

5.  Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

Authors:  W E Russell; R J Coffey; A J Ouellette; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant).

Authors:  K Abe; J M McKibbin; S Hakomori
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

7.  Density-dependent growth control of adult rat hepatocytes in primary culture.

Authors:  T Nakamura; Y Tomita; A Ichihara
Journal:  J Biochem       Date:  1983-10       Impact factor: 3.387

8.  Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.

Authors:  R Zarnegar; G Michalopoulos
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

9.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Expression of Ley antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC).

Authors:  M Adachi; M Hayami; N Kashiwagi; T Mizuta; Y Ohta; M J Gill; D S Matheson; T Tamaoki; C Shiozawa; S Hakomori
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  11 in total

1.  Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.

Authors:  Yu-An Yang; Gen-Mu Zhang; Lionel Feigenbaum; Ying E Zhang
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

2.  Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Andrew D Patterson; Joo-Youn Cho; Kristopher W Krausz; Frank J Gonzalez
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

3.  TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Misako Sato; Dong Wook Kang; Kristopher W Krausz; Kathleen C Flanders; Kazuo Ikeda; Hans Luecke; Lalage M Wakefield; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2012-10-03       Impact factor: 5.922

4.  Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats.

Authors:  Shyr-Ming Sheen-Chen; Chung-Ren Lin; Kuan-Hung Chen; Chien-Hui Yang; Chien-Te Lee; Hui-Wen Huang; Chun-Ying Huang
Journal:  J Gastroenterol       Date:  2013-10-06       Impact factor: 7.527

5.  Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.

Authors:  Tetsuya Shimizu; Shigeki Yokomuro; Yoshiaki Mizuguchi; Yutaka Kawahigashi; Yasuo Arima; Nobuhiko Taniai; Yasuhiro Mamada; Hiroshi Yoshida; Koho Akimaru; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

6.  Simultaneous segmental obstruction of bile duct and portal vein markedly changes a population of biliary and hepatic cells in human liver.

Authors:  Takanori Kyokane; Masato Nagino; Junichi Kamiya; Yuji Nimura; Tetsuro Nagasaka
Journal:  Langenbecks Arch Surg       Date:  2003-05-16       Impact factor: 3.445

7.  Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis.

Authors:  Wei Jiang; Chang-Qing Yang; Wen-Bin Liu; Yi-Qing Wang; Bo-Ming He; Ji-Yao Wang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

8.  TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence.

Authors:  Thomas G Bird; Miryam Müller; Luke Boulter; David F Vincent; Rachel A Ridgway; Elena Lopez-Guadamillas; Wei-Yu Lu; Thomas Jamieson; Olivier Govaere; Andrew D Campbell; Sofía Ferreira-Gonzalez; Alicia M Cole; Trevor Hay; Kenneth J Simpson; William Clark; Ann Hedley; Mairi Clarke; Pauline Gentaz; Colin Nixon; Steven Bryce; Christos Kiourtis; Joep Sprangers; Robert J B Nibbs; Nico Van Rooijen; Laurent Bartholin; Steven R McGreal; Udayan Apte; Simon T Barry; John P Iredale; Alan R Clarke; Manuel Serrano; Tania A Roskams; Owen J Sansom; Stuart J Forbes
Journal:  Sci Transl Med       Date:  2018-08-15       Impact factor: 17.956

9.  Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo.

Authors:  Ying Wang; Xiaoyuan Zhang; Yang Yang; Xiaohong Yang; Boping Ye
Journal:  Mar Drugs       Date:  2015-08-18       Impact factor: 5.118

10.  The role of growth factors on hepatic damage in rats with obstructive jaundice.

Authors:  Ozgur Turk; Bartu Badak; Ersin Ates; Emine Dundar; Emine Sutken
Journal:  Springerplus       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.